USMNT legend Kasey Keller reveals 16-year cancer journey [USA TODAY]
Bristol-Myers Squibb Company (BMY)
Last bristol-myers squibb company earnings: 2/6 07:05 am
Check Earnings Report
US:NYSE Investor Relations:
bms.com/investors.html
Company Research
Source: USA TODAY
Keller, 56, shared his story for the first time on World Cancer Day, thankfully also noting that he is in full remission. In 2010, Keller went in for an MRI for a hip injury during his time with the Seattle Sounders. Doctors noticed something concerning during the scan and five days later, the goalkeeper received a cancer diagnosis. Because the lymphoma was slow moving, doctors determined that it didn't require immediate treatment and Keller was able to continues his career. In 2011, Keller retired at age 41 and embarked on a career in broadcasting. Keller began experiencing weight loss and swollen lymph nodes in 2017, with doctors informing him that his diagnosis had changed to large B-cell lymphoma (LBCL). After trying several different treatment options with no success, Keller was among the first people to try the new drug Breyanzi when it was introduced in 2021. The results were immediate: Keller was in remission within two months and was given a declaration of “no eviden
Show less
Read more
Impact Snapshot
Event Time:
BMY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BMY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BMY alerts
High impacting Bristol-Myers Squibb Company news events
Weekly update
A roundup of the hottest topics
BMY
News
- Bristol-Myers Squibb (NYSE:BMY) Reports Strong Q4 CY2025 [Yahoo! Finance]Yahoo! Finance
- Bristol-Myers Squibb in charts: Q4 revenue from Eliquis, Opdivo, Yervoy, Orencia rises Y/Y; Sprycel and Pomalyst/ Imnovid falls [Seeking Alpha]Seeking Alpha
- Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2025Business Wire
- Blood thinners are a leading cause of drug-related harm. Can the risk be lowered? [MSNBC.com]MSNBC.com
- OXB Signs New Multi-Year Commercial Supply Agreement with Bristol Myers Squibb [Yahoo! Finance]Yahoo! Finance
BMY
Earnings
- 2/5/26 - Beat
BMY
Sec Filings
- 2/5/26 - Form 8-K
- 2/3/26 - Form 4
- 2/3/26 - Form 4
- BMY's page on the SEC website